1413 related articles for article (PubMed ID: 27210827)
1. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
[TBL] [Abstract][Full Text] [Related]
2. Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice.
Li L; Zhou N; Gong H; Wu J; Lin L; Komuro I; Ge J; Zou Y
Hypertens Res; 2010 Dec; 33(12):1289-97. PubMed ID: 20944638
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
4. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
Dang Z; Su S; Jin G; Nan X; Ma L; Li Z; Lu D; Ge R
J Ethnopharmacol; 2020 Mar; 250():112470. PubMed ID: 31862407
[TBL] [Abstract][Full Text] [Related]
5. The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.
Wang J; He W; Guo L; Zhang Y; Li H; Han S; Shen D
Mol Med Rep; 2017 Aug; 16(2):1973-1981. PubMed ID: 28656296
[TBL] [Abstract][Full Text] [Related]
6. Alteration of cardiac ACE2/Mas expression and cardiac remodelling in rats with aortic constriction.
Zhang Y; Li B; Wang B; Zhang J; Wu J; Morgan T
Chin J Physiol; 2014 Dec; 57(6):335-42. PubMed ID: 25575522
[TBL] [Abstract][Full Text] [Related]
7. Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis.
Liu J; Chen Q; Liu S; Yang X; Zhang Y; Huang F
Life Sci; 2018 Sep; 208():139-148. PubMed ID: 29990483
[TBL] [Abstract][Full Text] [Related]
8. Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.
Iwanami J; Mogi M; Tsukuda K; Wang XL; Nakaoka H; Ohshima K; Chisaka T; Bai HY; Kanno H; Min LJ; Horiuchi M
Hypertens Res; 2014 Jul; 37(7):616-20. PubMed ID: 24599018
[TBL] [Abstract][Full Text] [Related]
9. Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats.
Klimas J; Olvedy M; Ochodnicka-Mackovicova K; Kruzliak P; Cacanyiova S; Kristek F; Krenek P; Ochodnicky P
J Cell Mol Med; 2015 Aug; 19(8):1965-74. PubMed ID: 25766467
[TBL] [Abstract][Full Text] [Related]
10. Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
Xiao HL; Li CS; Zhao LX; Yang J; Tong N; An L; Liu QT
Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1159-1169. PubMed ID: 27449068
[TBL] [Abstract][Full Text] [Related]
11. Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
Nakamura K; Koibuchi N; Nishimatsu H; Higashikuni Y; Hirata Y; Kugiyama K; Nagai R; Sata M
Hypertens Res; 2008 Oct; 31(10):1953-61. PubMed ID: 19015603
[TBL] [Abstract][Full Text] [Related]
12. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
[TBL] [Abstract][Full Text] [Related]
13. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M
Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178
[TBL] [Abstract][Full Text] [Related]
14. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
[TBL] [Abstract][Full Text] [Related]
15. The ACE-2/Ang1-7/Mas cascade enhances bone structure and metabolism following angiotensin-II type 1 receptor blockade.
Abuohashish HM; Ahmed MM; Sabry D; Khattab MM; Al-Rejaie SS
Eur J Pharmacol; 2017 Jul; 807():44-55. PubMed ID: 28442323
[TBL] [Abstract][Full Text] [Related]
16. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Pernomian L; Pernomian L; Baraldi Araújo Restini C
Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
[TBL] [Abstract][Full Text] [Related]
17. Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.
Sukumaran V; Veeraveedu PT; Lakshmanan AP; Gurusamy N; Yamaguchi K; Ma M; Suzuki K; Kodama M; Watanabe K
Free Radic Res; 2012 Jul; 46(7):850-60. PubMed ID: 22497476
[TBL] [Abstract][Full Text] [Related]
18. Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats.
Awwad ZM; El-Ganainy SO; ElMallah AI; Khattab MM; El-Khatib AS
Toxicology; 2019 Dec; 428():152310. PubMed ID: 31629013
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling.
Iwai M; Nakaoka H; Senba I; Kanno H; Moritani T; Horiuchi M
Hypertension; 2012 Jul; 60(1):137-44. PubMed ID: 22665126
[TBL] [Abstract][Full Text] [Related]
20. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
Yamamoto K; Ohishi M; Katsuya T; Ito N; Ikushima M; Kaibe M; Tatara Y; Shiota A; Sugano S; Takeda S; Rakugi H; Ogihara T
Hypertension; 2006 Apr; 47(4):718-26. PubMed ID: 16505206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
